POZ October-November 2014
POZ October-November 2014
In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Features
PrEP and Prejudice
Can personal choice and public health find common ground in pre-exposure prophylaxis?
Remembering AIDS 2014
An analysis of the themes at the 20th International AIDS Conference in Melbourne, Australia.
HIV is Not A Crime
The aftermath of HIV criminalization advocacy in Iowa.
From the Editor
Die Another Day
At a personal level and with proper adherence, PrEP is highly effective at preventing HIV.
Feedback
Letters-October/November 2014
I had non-Hodgkin’s lymphoma in 2005 and was treated early and aggressively. I stayed on my HIV meds and have been cancer-free since.
POZ Q+A
All in the Familia
Bienestar marks 25 years of serving the HIV/AIDS and other health needs of Latinos in Southern California.
POZ Planet
Fighting Stigma
With cameras rolling, William Brawner discloses his HIV status.
The Fundraiser Formerly Known as AIDS Walk
After 27 years, AIDS Walk Washington is now renamed The Walk to End HIV.
End Times Are Coming?
Thirty years ago, New York was the epicenter of the AIDS crisis--today I am proud to announce that we are in a position to be the first state...
Now That’s One Way to Disclose
Morgan Molthrop had “HIV Positive / Bipolar / Recovering Addict” tattooed on his chest as a way to disclose all three conditions.
Documenting a Son’s Suicide
Do stigma and shame kill? That tragic idea is explored in the documentary Broken Heart Land.
Take a Tip From This HIV-Positive Former Smoker
Smoking and HIV don’t mix.
New Mexico Mysteries
Southwest CARE Center serves Santa Fe, Roswell and more.
POZ Stories: Theresa Kenney
Today, Kenney marks a 10-year relationship with a man who is HIV negative, and she is the very proud grandmother of three.
Voices
Stranger than Fiction
Journalist and author David M. Hancock apologizes in his opinion piece titled “True Story.”
Care and Treatment
Are Cigarettes Sending the Immune System Up in Smoke?
Smoking cigarettes appears to harm the immune systems of people with HIV who are on treatment for the virus and have a fully suppressed viral...
Pharma Giants Team Up for New Single-Tablet HIV Regimen
Janssen R&D Ireland and ViiV Healthcare are joining forces to develop a new two-drug, single-tablet regimen to treat HIV.
Cancer Treatment Eludes People With HIV
HIV-positive people are apparently less likely to receive treatment for cancer when compared with those who do not have the virus.
Portrait of a Slowing Epidemic
A new UNAIDS report found significant drops in the rate of new global HIV cases as well as AIDS-related deaths in recent years.
Perfect Efficacy for Gays Who Adhered to PrEP; Most Didn’t
Men and transgender women who have sex with men and who took Truvada as PrEP in a recent trial were totally protected against HIV if they adhe...
Success for Sovaldi in Those Coinfected With Hep C and HIV
Gilead Sciences’ Sovaldi (sofosbuvir) and ribavirin cured high rates of people coinfected with HIV and hepatitis C virus (HCV).
Research Notes
Prevention: Transmitting While on Meds?
While the chance is slim, HIV-positive heterosexuals who have been taking antiretrovirals (ARVs) longer than six months and who are in regular...
Treatment: Hold That Switcheroo
You may be better off staying the course than switching your HIV meds, provided you have little or no drug resistance.
Cure: Infant Treatment Shrinks Reservoir
Treating HIV-positive infants with an aggressive regimen of antiretrovirals (ARVs) shortly after birth can greatly reduce the establishment of...
Concerns: Virus Returns in
The famed “Mississippi Baby,” thought to be functionally cured of HIV, has experienced a resurgence of the virus.
POZ Survey Says
PrEP Talk
We asked readers to weigh in on their thoughts about the use of Truvada as a way for HIV-negative people to reduce their risk of infection.
POZ Heroes
Traveling Man
On July 29, 2014, after living more than two decades with HIV, Nello Carlini celebrated his 90th birthday.
